Novo Nordisk to phase out human insulin pens: report

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...
FiercePharma

Citing 'capacity constraints,' Novo Nordisk plots global wind-down of human insulin pen production

As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities. “To address our current capacity ...
WKBW

Novo Nordisk recalls faulty cartridge holders in insulin pens due to potential health risks

Novo Nordisk has voluntarily recalled insulin cartridge holders used in six NovoPen Echo batches because they may crack or break if exposed to certain chemicals, like certain cleaning agents. Using a ...
Reuters

Novo Nordisk says it is gradually phasing out human insulin pens globally

LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of ...
WKRG

Diabeloop Announces Collaboration With Novo Nordisk to Pursue Its Interoperability Strategy With Connected Insulin Pens

On the occasion of the annual congress of the Société francophone du diabète (SFD), in Montpellier, March 21-24, Diabeloop announces a collaboration with Novo Nordisk, a major global healthcare ...
MarketWatch

Japan Insulin Pen Market Growth Outlook and Company Analysis Report 2025-2033 Featuring B. Braun Melsungen, Eli Lilly and C, Becton, Dickinson, Novo Nordisk, Ypsomed, Terumo ...

The "Japan Insulin Pen Market Growth Outlook 2025-2033" has been added to ResearchAndMarkets.com's offering. The Japan Insulin Pen Market is forecasted to rise from US$ 304.26 Million in 2024 to US$ ...